. The most common neurologic manifestations of WNV are aseptic meningitis, meningoencephalitis, and encephalitis with or without acute fl accid paralysis (3). Other less common neurologic manifestations include Guillain-Barré syndrome, chorioretinitis, stroke-like symptoms, and unilateral brachial plexopathy (4, 5) .
We report a case of WNV aseptic meningitis in a 39-year-old immunocompetent woman who had severe headache with newonset stuttering. Her medical history included lumbar disc herniation and migraines, for which she was taking sumatriptan. Her symptoms started ≈2 weeks before hospitalization and included a severe generalized headache initially thought to be a migraine, but sumatriptan resulted in no improvement. A few days later, she had fever and was intermittently stuttering. She denied recent travel or animal exposure but admitted to having received multiple mosquito bites during the preceding weeks.
At The patient began treatment with acyclovir, 10 mg/kg intravenously, every 8 hours for 3 days. On hospital day 2, she underwent magnetic resonance imaging of the brain; results were within reference limits. On hospital day 3, her headache began to improve and she became afebrile, but she still stuttered occasionally. Results of CSF tests for enterovirus, herpes simplex viruses 1 and 2, and varicella zoster virus and PCR for human herpesvirus 6 were negative, and acyclovir was discontinued. On hospital day 5, she was discharged. Three days later, serum and CSF ELISA results for WNV were positive. A WNV ELISA was performed at ViroMed Laboratories (Minnetonka, MN, USA) by using a Focus Test Kit (Focus Diagnostics, Cypress, CA, USA), and the result was positive. The patient subsequently reported that her stuttering had ceased.
A high degree of clinical suspicion for WNV infection should be considered in patients with a recent history of mosquito bites and an acute febrile illness associated with neurologic signs and symptoms (5) . Typical CSF fi ndings of infection with WNV include lymphocytic pleocytosis, elevated protein level, reference glucose and lactic acid levels, and no erythrocytes (6) .
The clinical presentation of WNV infection varied widely from asymptomatic seroconversion to fatal encephalitis. It is possible, but unlikely, that the stuttering in the patient was an indication of a migraine aura. Initially, the patient reported that the headache might have been a migraine, but later reported that its associated symptoms, e.g., photophobia, were not as severe and did not last as long as her usual migraines. Further argument against migraine aura is the lack of response to her migraine medication and the fact that the stuttering continued after the headache resolved.
Because WNV resembles JEV, it is interesting to note that a case of stuttering in a young adult infected with JEV has been reported (7). However, the mechanism of stuttering associated with WNV is unknown. One possible explanation is myoclonic contractions of the tongue, i.e., vocal myoclonus.
No Evidence of Dengue Virus Circulation in Rural Gabon
To the Editor: Dengue virus (DENV) is a mosquito-borne RNA virus belonging to the family Flaviviridae. It is composed of 4 closely related serotypes designated DENV-1-4. There are 2 transmission cycles for this virus. The endemic/ epidemic cycle involves humans and the mosquito species Aedes aegypti and Ae. albopictus. The zoonotic or sylvatic cycle involves monkeys and sylvatic Aedes spp. mosquitoes (1) .
Despite occasionally severe clinical forms, human dengue usually consists of a self-limited febrile disease often associated with asthenia, headache, rash, arthralgia, and myalgia. DENV is widely distributed throughout Asia, the Pacifi c, Central and South America, the Middle East, and Africa (2, 3) . In Africa, most DENV outbreaks have been reported in the eastern regions, and episodic cases have occurred in western regions. However, few data are available for central regions.
In Gabon, concurrent of transmission of DENV and chikungunya virus was documented in 2007 during a large outbreak of dengue (4). This outbreak affected Libreville and major cities in northwestern Gabon and was caused by DENV-2. DENV isolates were closely related to strains from Asia, suggesting that the outbreak resulted from recent introduction of the virus. Epidemic DENV strains are constantly moving from one region to another, and local DENV transmission from sylvatic to urban areas has been documented in some countries in Africa (5, 6) .
To examine possible circulation of DENV in Gabon, we tested the following for antibodies against dengue: villagers living in rural areas, pet monkeys in the same areas, and wild monkeys killed in forests for bushmeat. A total of 4,341 persons and 186 pet monkeys were sampled during (Table) .
DENV-specifi c immunoglobulin (Ig) G and IgM were detected by using capture ELISA kits (Panbio; Brisbane, Queensland, Australia) (7) according the manufacturer's instructions. All samples were tested with an IgG assay, which was designed to detect high antibody titers usually associated
